Johnson & Johnson testing COVID-19 vaccine in adolescents between 12 and 17 years old

Johnson & Johnson has expanded a clinical trial of its experimental coronavirus vaccine to include adolescents 12 to 17 years old, the drugmaker announced Friday. The ongoing, placebo-controlled trial was initially designed to evaluate the safety and efficacy of the shots for people ages 18 and older. The company now plans to test its vaccine in “a small number” of 16- and 17-year-olds before expanding it to a larger pool of younger volunteers, according to a news release. “The COVID-19 pandemic has had a profound impact on adolescents, not just with the complications of the disease, but with ...